Polysaccharide-based nanoparticles for theranostic nanomedicine. - Wikidata - awgldk - TriplyDB

Polysaccharide-based nanoparticles for theranostic nanomedicine.

Polysaccharide-based nanoparticles for theranostic nanomedicine.

http://www.wikidata.org/entity/Q36703343

about

Cyanine based Nanoprobes for Cancer Theranostics.Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging In vivo antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma.An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery.Self-assembled nanogel of cholesterol-bearing xyloglucan as a drug delivery nanocarrier.Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer.Nano based drug delivery systems: recent developments and future prospects A Semimetal-Like Molybdenum Carbide Quantum Dots Photoacoustic Imaging and Photothermal Agent with High Photothermal Conversion Efficiency

P2860

Q30101038-09D0833E-50D9-4FE7-B618-8A317E976BB0 Q33677934-96FCEA33-2E75-4BA2-B804-6D42B4288B5C Q38730342-5182AD53-A4E8-47D2-AC34-A375A7220092 Q38928173-D6C2D873-EC85-4DA2-8220-96062B3BF8BD Q39135714-137DD25D-9AEB-4B0E-9F4D-13AA4D8BDEF8 Q47769437-9C7F1B03-1E94-4C74-90B1-8C67D1C0AE29 Q47961163-7579C0C3-4753-45C8-AB67-A9346FC1F039 Q50910141-5DF94476-DB51-45E7-8E4F-7D60C65FE458 Q54958449-3AE9C931-DB0B-4553-87E8-41E985C9F8D6 Q54989481-E0225DC8-17AB-42A1-9D05-355D56B348ED Q57154808-569068C3-57C4-4024-A019-9BBD8DCBFEA3 Q58716499-B8B2ADAC-C472-493C-BB63-0FE6CC96C23A

P2860

Polysaccharide-based nanoparticles for theranostic nanomedicine.

http://www.wikidata.org/entity/Q36703343

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@ast

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@en

type

label

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@ast

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@en

prefLabel

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@ast

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@en

P1433

Q36703343-F0A0F05F-B6E6-473C-96A6-AC9EDBD318BF

P1476

Q36703343-D7AE7F92-04A2-491C-86AD-0E4C570D8E71

P2093

Q36703343-2DCA39E6-F6F9-4913-8A1C-97D691FD3AA8

Q36703343-5B28DF28-2190-40B8-8E82-9CC81F7EC949

Q36703343-73AD9B1B-EB72-448F-9C34-A6BF6F434A73

Q36703343-9DE11DFA-7339-4CF4-8674-D9B6FC65664C

Q36703343-A0B60DB6-CDB2-4D14-B4D9-F411CE8AF3D9

P2860

Q36703343-090E019C-858A-4E00-AF89-308616D335AE

Q36703343-0A5D8335-7CD4-4ED1-938E-EBE15D38E430

Q36703343-0A7D1988-E3F1-4C02-991B-733CA30FE04F

Q36703343-0C41492B-DD71-432B-BEFA-F1FB09E8E7C0

Q36703343-16175E46-65B9-43E6-9A99-960EAE72C0EB

Q36703343-16874766-2E45-4249-9B4D-6AC51B75755D

Q36703343-1804EAD9-83BD-46EE-8309-897B420756EF

Q36703343-1A8582E2-4A19-4F61-AC71-5E96B91232EE

Q36703343-1AA3D0DA-C335-4E5A-B184-CF49597DF96E

Q36703343-1CA8FF41-0452-4B7D-B341-ED0F4AA68E56

P304

Q36703343-14E198E4-82FE-4791-8BE5-C4891EB412A7

P31

Q36703343-0C037B60-54F4-4406-ABB9-E44D328514EF

P356

Q36703343-2752980F-1563-4343-9B03-D39E4FD58317

P407

Q36703343-D3F1EC84-1228-45C9-B691-FF3065968C62

P433

Q36703343-B0543BBF-AA45-462C-867E-4651504ED2F4

P478

Q36703343-299B8E7F-7FA2-4438-A71B-3C6ACE2C6742

P577

Q36703343-82CA62F9-5462-4DB4-B55C-E6E9BA35C189

P698

Q36703343-EDCDCC62-3BC4-4BE4-9D08-40CB167CDD72

P921

Q36703343-7FE6FBAF-D623-42BA-9E4D-D65E83D71BB5

Q36703343-B1BF8889-E2CC-4E6F-AC2E-0D00F9424489

P932

Q36703343-C60592CC-7129-471B-AFEC-E44BCF8102FB

P356

J.ADDR.2015.11.015

P1433

Advanced Drug Delivery Reviews

P1476

Polysaccharide-based nanoparticles for theranostic nanomedicine.

@en

P2093

H S Han

http://www.w3.org/2001/XMLSchema#string

J H Park

http://www.w3.org/2001/XMLSchema#string

K Kim

http://www.w3.org/2001/XMLSchema#string

M Swierczewska

http://www.w3.org/2001/XMLSchema#string

S Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted nanotechnology for cancer imaging.

CD44: from adhesion molecules to signalling regulators

Nanoparticle therapeutics: an emerging treatment modality for cancer

Nanocarriers as an emerging platform for cancer therapy

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Imaging and drug delivery using theranostic nanoparticles

Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics.

Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging.

Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA.

Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy.

P304

70-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ADDR.2015.11.015

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt A

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26639578

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

4798864

http://www.w3.org/2001/XMLSchema#string